乳がんにおける機能的食品と運動:表遺伝子調節,化学療法耐性,疲労管理
1Sports Department of Xi'an Polytechnic University, Xi'an, Shaanxi, China.
Frontiers in nutrition
|August 29, 2025
まとめ
機能性食品と運動は 乳がん (BC) を分子と表遺伝的経路で制御する有望な効果を示しています これらのライフスタイルの介入は,BCの予防と治療に相乗効果をもたらし,治療への反応と生活の質を向上させます.
科学分野:
- 腫瘍学
- 栄養学
- 運動 生理学
背景:
- 乳がん (BC) は,世界の女性における主要な悪性腫瘍です.
- 栄養と運動を含む 変更可能なライフスタイルの要因が 癌に及ぼす影響が 認識されつつあります
- これらの要因がBCリスク,進行,治療に与える影響を理解することは極めて重要です.
研究 の 目的:
- 乳がん (BC) の調節における機能性食品と運動の役割を検討する.
- これらの効果の根底にある分子と表遺伝的メカニズムを探求する.
- BCの予防と治療における補助的な戦略としてその可能性を評価する.
主な方法:
- 乳がんにおける機能性食品と運動に関する研究の文献レビュー.
- 分子と表遺伝的メカニズム (DNAメチル化,ヒストンの修正,マイクロRNAの調節) の分析.
- 炎症,免疫機能,ホルモンバランス,アポトーシスへの影響の検討
主要な成果:
- 機能的な食品は,表遺伝的変化を通してBC生物学に影響を与えます.
- 運動は癌に関連する 重要な細胞経路を調整します
- 併用した介入は,腫瘍の成長を抑制し,治療を強化するシナジスティックな可能性を示しています.
結論:
- 機能性食品と運動はBC調節のための有望な無毒戦略です.
- エピジェネティックと細胞経路は これらのライフスタイル介入の 重要なターゲットです
- 精密ながん治療のための組み合わせた戦略を最適化するためにさらなる臨床試験が必要です.
関連する概念動画
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448


